Clinical outcomes of linezolid and vancomycin in patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus stratified by baseline renal function: a retrospective, cohort analysis

被引：0
|
作者：
Ping Liu
Blair Capitano
Amy Stein
Ali A. El-Solh
机构：
[1] Global Established Pharma Business,Clinical Pharmacology
[2] Specialty Care,Medical Affairs
[3] Pfizer Inc.,Customer Solutions
[4] Biostatistics,Division of Pulmonary, Critical Care and Sleep Medicine
[5] Quintiles,VA Western New York Healthcare System
[6] University at Buffalo,undefined
[7] Medical Research,undefined
[8] Bldg. 20 (151) VISN02,undefined
来源：
BMC Nephrology | / 18卷
关键词：
Outcomes; Linezolid; Vancomycin; Pneumonia; MRSA; Renal function;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Clinical outcomes of linezolid and vancomycin in patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus stratified by baseline renal function: a retrospective, cohort analysis
    Liu, Ping
    Capitano, Blair
    Stein, Amy
    El-Solh, Ali A.
    BMC NEPHROLOGY, 2017, 18
  • [2] Linezolid versus vancomycin for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus in the elderly: A retrospective cohort analysis Effectiveness of linezolid in the elderly
    Takada, Hiroaki
    Hifumi, Toru
    Nishimoto, Naoki
    Kanemura, Takashi
    Yoshioka, Hayato
    Okada, Ichiro
    Kiriu, Nobuaki
    Inoue, Junichi
    Koido, Yuichi
    Kato, Hiroshi
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2017, 35 (02): : 245 - 248
  • [3] Linezolid Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: Controversy Continues
    Masuta, Kana
    Oba, Yuichiro
    Iwata, Kentaro
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (01) : 161 - 161
  • [4] Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia -: The subtleties of subgroup analyses
    Powers, JH
    Ross, DB
    Lin, D
    Soreth, J
    CHEST, 2004, 126 (01) : 314 - 315
  • [5] Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus
    Mullins, C. Daniel
    Kuznik, Andreas
    Shaya, Fadia T.
    Obeidat, Nour A.
    Levine, Andrew R.
    Liu, Larry Z.
    Wong, Winston
    CLINICAL THERAPEUTICS, 2006, 28 (08) : 1184 - 1198
  • [6] Nosocomial methicillin-resistant staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy
    Mathias W Pletz
    Olaf Burkhardt
    Tobias Welte
    European Journal of Medical Research, 15
  • [7] NOSOCOMIAL METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) PNEUMONIA LINEZOLID OR VANCOMYCIN? - COMPARISON OF PHARMACOLOGY AND CLINICAL EFFICACY
    Pletz, Mathias W.
    Burkhardt, Olaf
    Welte, Tobias
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (12) : 507 - 513
  • [8] Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus
    Patel, Dipen A.
    Shorr, Andrew F.
    Chastre, Jean
    Niederman, Michael
    Simor, Andrew
    Stephens, Jennifer M.
    Charbonneau, Claudie
    Gao, Xin
    Nathwani, Dilip
    CRITICAL CARE, 2014, 18 (04)
  • [9] Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus
    Dipen A Patel
    Andrew F Shorr
    Jean Chastre
    Michael Niederman
    Andrew Simor
    Jennifer M Stephens
    Claudie Charbonneau
    Xin Gao
    Dilip Nathwani
    Critical Care, 18
  • [10] Vancomycin dosing for methicillin-resistant staphylococcus aureus nosocomial pneumonia
    Hall, Ronald G., II
    CHEST, 2007, 132 (03) : 1100 - 1101
12345